Radboud University Nijmegen Medical Center
Nijmegen, Gelderland, 6500HB, Netherlands
NCT Number: NCT01236625
Official title:
LAPAD - A prospective study on the effect of adhesiolysis during elective laparotomy or laparoscopy on per- and postoperative complication, quality of life and socioeconomic costs
Background:
With improved surgical technology and ageing of the population the number of reoperations in the abdomen dramatically increases. The risk for a repeat laparotomy or laparoscopy is a high as 30% in the first ten years after a laparotomy. In over 95% of reoperations adhesiolysis is required to gain access to the abdominal cavity and operation area. Adhesiolysis significantly increases the risk for inadvertent organ damage, such as enterotomies, leading to higher morbidity, mortality and socioeconomic costs.
Purpose:
To define the impact of adhesiolysis on per- and postoperative complications, quality of life and socioeconomic costs.
Design:
Prospective observational study.
Primary outcomes:
* adhesiolysis time * inadvertent enterotomy * seromuscular injury * miscellaneous organ damage * Serious adverse events of operation (anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death)
Secondary outcomes:
* Hospital stay * Intensive care admission * Reinterventions * In-hospital costs * Parenteral feeding * Short term readmissions (30 days) * Quality of life (Gastro- intestinal tract complaints, Short Form- 36(SF-36), DASI (Duke Activity Score Index(DASI) )
Estimated enrollment: 800 start study: 1 june 2008 Inclusion completion date: 1 june 2010 Estimated study completion date: 1 february 2011
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nijmegen, Gelderland, 6500HB, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blunt or sharp dissection of adhesive tissue.
Time frame: Day of surgery (one day)
Every unintended and iatrogenic full thickness defect of the bowel.
Time frame: Day of surgery (one day)
Every visible damage to the serosa, without leakage or exposure of the bowel lumen.
Time frame: Day of surgery (one day)
Unintended iatrogenic damage to intra- peritoneal organs and structures other than bowel. E.g. Spleen, liver, pancreas or ureter.
Time frame: 30 days
Complications marked as SAE: anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death
Time frame: Day of surgery (one day)
Time required to dissect adhesive tissue.
Time frame: From surgery to discharge
Number of days from surgery until discharge
Time frame: 30 days after discharge
Emergency reoperation related to a complication of initial surgery within max. 30 days after discharge.
Time frame: From surgery to discharge
Direct costs comprising costs from operation, stay on ward and Intesive Care Unit, medication use, diagnostics.
Time frame: From surgery to discharge
Number of days that patient required parenteral feeding.
Time frame: 30 days after discharge
Readmissions to the hospital related to complication of surgery.
Time frame: 6 months post surgery
Quality of life as measured with SF-36, Gastro- intestinal tract complaints and DASI index.
Radboud University Medical Center
Other
A Prospective Study on the Effect of Adhesiolysis During Elective Laparotomy or Laparoscopy on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs
Acronym: LAPAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02260115
Cicatrix, Fibrosis
Neuss, Germany
View Trial DetailsNCT00966056
Adhesions of Nasal Cavity, Cicatrix
Hubli, Karnataka, India
View Trial DetailsNCT00882167
Cicatrix, Fibrosis
Arnhem, Gelderland, Netherlands
View Trial DetailsNCT07523698
Adhesion; Bladder, Adhesions Uterus
Adana, Yuregir, Turkey (Türkiye)
View Trial Details